MERLO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 29.524
AS - Asia 19.037
EU - Europa 18.222
SA - Sud America 2.598
AF - Africa 572
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 32
Totale 70.038
Nazione #
US - Stati Uniti d'America 28.796
SG - Singapore 6.975
IT - Italia 6.114
CN - Cina 4.297
PL - Polonia 2.245
BR - Brasile 1.948
VN - Vietnam 1.945
HK - Hong Kong 1.696
DE - Germania 1.621
SE - Svezia 1.529
FR - Francia 1.159
KR - Corea 1.094
BD - Bangladesh 1.069
GB - Regno Unito 898
NL - Olanda 824
FI - Finlandia 730
RU - Federazione Russa 716
UA - Ucraina 546
IN - India 446
BG - Bulgaria 393
CA - Canada 375
IE - Irlanda 354
TR - Turchia 314
AR - Argentina 215
JP - Giappone 204
CH - Svizzera 195
MX - Messico 192
ES - Italia 190
AT - Austria 182
MA - Marocco 147
ZA - Sudafrica 135
ID - Indonesia 130
IQ - Iraq 112
EC - Ecuador 91
CL - Cile 79
CO - Colombia 79
BE - Belgio 78
PK - Pakistan 78
SA - Arabia Saudita 69
EG - Egitto 65
RO - Romania 64
VE - Venezuela 63
PH - Filippine 60
CZ - Repubblica Ceca 56
GR - Grecia 54
IR - Iran 53
AE - Emirati Arabi Uniti 47
PT - Portogallo 47
PE - Perù 45
AU - Australia 41
UZ - Uzbekistan 41
JO - Giordania 40
PY - Paraguay 38
SN - Senegal 37
KE - Kenya 36
LT - Lituania 36
MY - Malesia 35
KZ - Kazakistan 33
TH - Thailandia 33
DZ - Algeria 32
TW - Taiwan 31
AZ - Azerbaigian 30
IL - Israele 30
TN - Tunisia 26
EU - Europa 25
RS - Serbia 25
NP - Nepal 24
UY - Uruguay 23
CR - Costa Rica 22
OM - Oman 20
AL - Albania 19
JM - Giamaica 19
LV - Lettonia 19
PA - Panama 19
KG - Kirghizistan 17
SK - Slovacchia (Repubblica Slovacca) 16
BO - Bolivia 15
DO - Repubblica Dominicana 15
HN - Honduras 15
HU - Ungheria 15
BY - Bielorussia 14
DK - Danimarca 14
ET - Etiopia 13
CY - Cipro 12
SI - Slovenia 12
TT - Trinidad e Tobago 12
HR - Croazia 11
KW - Kuwait 11
LK - Sri Lanka 11
NG - Nigeria 11
NI - Nicaragua 11
GT - Guatemala 10
MD - Moldavia 10
TG - Togo 10
GE - Georgia 9
LB - Libano 9
NO - Norvegia 9
NZ - Nuova Zelanda 9
SV - El Salvador 9
AO - Angola 8
Totale 69.856
Città #
Singapore 4.170
Ashburn 3.895
Fairfield 2.069
San Jose 2.001
Chandler 1.800
Warsaw 1.798
Hong Kong 1.623
Woodbridge 1.501
Ann Arbor 1.108
Houston 1.106
Seoul 1.066
Hefei 1.043
Beijing 975
Trieste 920
Seattle 907
Wilmington 878
Chicago 754
Cambridge 718
Dallas 651
Los Angeles 643
Boardman 629
Ho Chi Minh City 600
Council Bluffs 565
Milan 559
Jacksonville 549
Princeton 460
Hanoi 435
Helsinki 400
Lauterbourg 399
New York 394
Santa Clara 387
Sofia 382
London 367
Zgierz 363
Munich 361
Dublin 343
Rome 343
Columbus 341
Frankfurt am Main 282
Moscow 263
The Dalles 252
Buffalo 239
São Paulo 203
Izmir 189
Amsterdam 180
Dearborn 162
Naples 145
Orem 138
San Diego 131
Tokyo 130
Montreal 123
Düsseldorf 121
Bern 115
Salt Lake City 111
Atlanta 110
Da Nang 106
Casablanca 105
Lappeenranta 104
Nuremberg 104
Vienna 104
Grafing 103
Toronto 103
Phoenix 98
Bologna 97
Denver 94
Venice 89
Shanghai 88
Redondo Beach 86
Turku 86
Chennai 84
Guangzhou 84
Turin 84
Washington 84
Florence 78
Brooklyn 77
Haiphong 70
Bremen 69
Brussels 68
Dong Ket 68
Stockholm 64
Johannesburg 63
Boston 62
Miano 60
Poplar 59
Venezia 59
Mexico City 58
Memphis 57
Verona 56
Des Moines 55
Paris 54
Rio de Janeiro 54
San Francisco 54
Udine 54
Jinan 53
Manchester 53
Redwood City 53
Mumbai 52
Pune 52
Tampa 52
Elk Grove Village 51
Totale 43.705
Nome #
Does Ectopic Beats Bring More Discriminatory Information to Diagnose Ischemic Heart Disease? 471
Arresto cardiaco extraospedaliero: le competenze degli studenti dell’Università degli Studi di Trieste sulle manovre rianimatorie e l’utilizzo del defibrillatore automatico esterno 465
Natural History of Dilated Cardiomyopathy in Children 434
Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias 427
Role of Titin Missense Variants in Dilated Cardiomyopathy 424
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 408
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 408
Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist? 407
Miocardite, cardiomiopatia infiammatoria e perimiocardite: possiamo fare ordine? 406
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures 402
Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives 376
I dieci punti che il cardiologo deve conoscere su scintigrafia miocardica con traccianti ossei, amiloidosi e cuore 370
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 361
Conflicting gender-related differences in the natural history of patients with idiopathic dilated cardiomyopathy 361
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 338
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History 328
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 325
Documento di consenso Società Italiana di Cardiologia- Società Italiana di Nefrologia: Ruolo dell’asse cardio-renale nella prevenzione e trattamento delle patologie cardiovascolari – Parte II: Dalle strategie di prevenzione al trattamento del paziente con coinvolgimento cardio-renale 323
Impact of Aging on Heart Rate Variability Properties of Healthy Subjects 319
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 310
Deleterious impact of mild anemia on survival of young adult patients (age 45 ± 14 years) with idiopathic dilated cardiomyopathy: data from the Trieste Cardiomyopathies Registry. 306
Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy 302
Contemporary etiology and prognosis of dilated non-ischemic cardiomyopathy 297
Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? 295
Dieci quesiti in tema di miocardite eosinofila [Ten questions about eosinophilic myocarditis] 291
Cardiac amyloidosis: a changing epidemiology with open challenges 289
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 287
Infiltrative/storage cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 283
Com'è cambiata la storia naturale della cardiomiopatia dilatativa? 281
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 280
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 277
Prognostic impact of short-term changes of E/E' ratio and left atrial size in dilated cardiomyopathy 274
Historical Terminology, Classifications, and Present Definition of DCM. 274
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 273
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 273
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 267
null 266
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 264
Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation 264
Influence of Aging on Short- and Long-term Heart Rate Variability in Patients with Heart Failure 263
Interchangeability of B type natriuretic peptide measurements in lithium heparin and K2EDTA: agreement between matrices and differences in diagnostic accuracy. 261
Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseases 260
Chapter 6: Clinical Presentation, Spectrum of Disease, and Natural History 259
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry 258
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 256
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 256
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 256
Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure 255
HRV analysis in CHF patients with different etiologies by means of spectral and nonlinear indexes 255
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis 255
Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy 253
Chapter 12: Prognostic Stratification and Importance of Follow-Up 251
Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathy 250
Genetics of Dilated Cardiomyopathy: Clinical Implications 249
Treatment of Functional Mitral Regurgitation in Heart Failure 248
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 247
Emergency Surgery and Cardiac Devices 246
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 246
Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. 245
Myocarditis in Clinical Practice 244
Cardiovascular aging: the unveiled enigma from bench to bedside 244
Evolving concepts in dilated cardiomyopathy 239
ECG in dilated cardiomyopathy: Specific findings and long-term prognostic significance 238
Myocarditis evolving in cardiomyopathy: When genetics and offending causes work together 238
Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF 237
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle 237
Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. 236
Early right ventricular response to cardiac resynchronization therapy: Impact on clinical outcomes 236
Idiopathic dilated cardiomyopathy and persistent viral infection: Lack of association in a controlled study using a quantitative assay. 234
Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy 234
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy 233
Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathyhttps://arts.units.it/submit?resume=115962# 233
Chapter 14: Unresolved Issues and Future Perspectives 233
Arrhythmogenic right ventricular cardiomyopathy: Arrhythmogenic right ventricular cardiomyopathy: Clinical assessment and differential diagnosis 231
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction 230
Echocardiographic evaluation of systolic and mean pulmonary artery pressure in the follow-up of patients with pulmonary hypertension. 229
The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM 229
Predictors for Restoration of Normal Left Ventricular Function in Response to Cardiac Resynchronization Therapy Measured at Time of Implantation. 228
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 227
Left Atrial Reverse Remodeling in Dilated Cardiomyopathy 226
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment. 226
DEFINITION, CLASSIFICATION, EPIDEMIOLOGY, AND CLINICAL RELEVANCE OF CARDIOMYOPATHIES. 225
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors 225
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers 224
Chapter 3: Pathophysiology 223
Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. 222
ICD replacement in patients with intermediate left ventricular dysfunction under optimal medical treatment 222
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 221
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies 220
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 220
[Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment]. 219
Clinical Echocardiography and Other Imaging Techniques in Cardiomyopathies 219
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 219
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 219
Apoptosis in patients with acute myocarditis. 218
Dilated Cardiomyopathy. From Genetics to Clinical Management 216
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy 215
Clinical management of dilated cardiomyopathy: Current knowledge and future perspectives 215
Role of the Electrocardiogram in Differentiating Genetically Determined Dilated Cardiomyopathy from Athlete's Heart 214
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 214
Totale 27.387
Categoria #
all - tutte 209.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 209.554


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.283 127 226 249 252 187 307 153 94 379 336 235 738
2022/20235.556 425 710 545 844 464 872 84 467 589 120 277 159
2023/20244.941 362 263 224 363 434 522 769 722 124 188 531 439
2024/202511.760 327 646 1.084 959 978 940 742 693 1.311 1.589 1.148 1.343
2025/202631.344 3.375 1.774 2.570 2.837 2.390 2.442 3.779 1.155 3.320 3.840 2.247 1.615
2026/2027137 137 0 0 0 0 0 0 0 0 0 0 0
Totale 71.799